Using CBD & Other Hemp Products? You're Not Alone, Study Finds

Follow Drugslib on

Medically reviewed by Drugs.com.

By Ernie Mundell HealthDay Reporter

THURSDAY, Dec. 14, 2023 -- The market for cannabidiol (CBD) and other products derived from the hemp plant is now wide open in the United States, but that could bring danger to consumers, the authors of a new report warn.

Many people may not realize it, but there's a largely legal market for products derived from hemp, which has a much lower content of the active ingredient found in the cannabis plant, delta-9-tetrahydrocannabinol (better known as THC).

This legal market arose after the 2018 Farm Bill removed hemp-derived cannabinoids from the federal Controlled Substances Act.

These hemp products are defined as containing less than 0.3 percent THC.

Now, a new study from the University of Michigan finds consumers quickly took advantage of the legislation.

In addition, “while the de-scheduling of hemp products initially opened up the market for CBD products, it also applies to the 100-plus cannabinoids also found in the plant," noted study lead author Kevin Boehnke.

"That means, as with CBD, all of them can follow that same path and be sold in gas stations, as ingredients in cosmetics, as well as in dispensaries -- there will likely be substantial proliferation of some of these compounds,” Boehnke said in a university news release. He's a research assistant professor of anesthesiology at the university, where he works in the Chronic Pain and Fatigue Research Center.

Just how popular have hemp-based products become?

To find out, the Michigan team analyzed 2023 data from a representative sample of almost 1,200 adults, surveyed by the National Opinion Research Center.

Typical hemp-derived products include those containing CBD, Delta 8-THC, cannabigerol (CBG), and cannabinol (CBN), the researchers explained.

The survey found that while 72% of participants had heard of CBD, fewer fewer had heard of delta-8-THC (41%), CBG (18%), or CBN (17%).

Along the same lines, 21% said they'd used CBD in the past year, compared with 12% for delta-8-THC, 5% for CBG, and 4% for CBN, Boehnke's group said.

The new study was published Dec. 13 in the journal JAMA Network Open.

The study also found that if respondents lived in a state where the use of medical or recreational marijuana was still illegal, they were more likely to use legal hemp-derived products.

That's a concern, Boehnke said, since these products face very little regulation or safety monitoring. Some might contain dangerous pesticides or solvents, or may not even contain ingredients that are listed on their labels.

“Not only are people with medical conditions being sold products with uncertain therapeutic effects, but these products may contain contaminants that are harmful,” warned Boehnke.

He also noted that some of the products produce effects not much different from standard marijuana.

“Delta-8-THC [a hemp product] purportedly has quite similar effects to delta-9-THC (better known as THC)," he said. "In other words, there is a loophole where people in states without legal cannabis can get high legally on delta-8-THC. It makes sense then that people who don’t have access to regulated markets would be more likely to use it."

Sources

  • University of Michigan, news release, Dec. 13, 2023

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-12-14 22:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords